Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

被引:12
|
作者
Alenazi, Aqeel M. [1 ]
Alhowimel, Ahmed S. [1 ]
Alshehri, Mohammed M. [2 ]
Alqahtani, Bader A. [1 ]
Alhwoaimel, Norah A. [1 ]
Segal, Neil A. [3 ]
Kluding, Patricia M. [4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Hlth & Rehabil Sci, Alkharj 11942, Saudi Arabia
[2] Jazan Univ, Dept Phys Therapy, Jazan 45142, Saudi Arabia
[3] Univ Kansas, Dept Phys Med & Rehabil, Med Ctr, Kansas City, KS 66160 USA
[4] Univ Kansas, Dept Phys Therapy & Rehabil Sci, Med Ctr, Kansas City, KS 66160 USA
关键词
osteoarthritis; diabetics; high blood glucose; pain intensity; symptoms; gait; pace; RADIOGRAPHIC KNEE OSTEOARTHRITIS; EARLY POSTOPERATIVE OUTCOMES; CLINICALLY DIAGNOSED KNEE; HAND OSTEOARTHRITIS; RISK-FACTORS; METABOLIC SYNDROME; GENERALIZED OSTEOARTHRITIS; UNITED-STATES; WALKING SPEED; ASSOCIATION;
D O I
10.3390/diagnostics13081386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Breast cancer research: where we are and where we should go
    Edison T Liu
    Breast Cancer Research, 2
  • [22] Community Deception in Networks: Where We Are and Where We Should Go
    Fionda, Valeria
    Pirro, Giuseppe
    COMPLEX NETWORKS & THEIR APPLICATIONS X, VOL 2, 2022, 1016 : 144 - 155
  • [23] The burden of blood pressure: Where are we and where should we go?
    Hamet, P
    CANADIAN JOURNAL OF CARDIOLOGY, 2000, 16 (12) : 1483 - 1487
  • [24] Uterine fibroid embolization: where are we and where should we go?
    Pelage, JP
    Fauconnier, A
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 25 (06) : 527 - 534
  • [25] Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?
    Martin, R
    Stürzebecher, CS
    McFarland, HF
    NATURE IMMUNOLOGY, 2001, 2 (09) : 785 - 788
  • [26] ISNT THIS WHERE WE SHOULD GO
    FLAHERTY, JA
    SMPTE JOURNAL, 1994, 103 (01): : 41 - 44
  • [27] Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go
    Yu, Yunxian
    NUTRIENTS, 2023, 15 (09)
  • [28] Dissemination research in cancer control: where are we and where should we go?
    Bowen, Deborah J.
    Sorensen, Glorian
    Weiner, Bryan J.
    Campbell, Marci
    Emmons, Karen
    Melvin, Cathy
    CANCER CAUSES & CONTROL, 2009, 20 (04) : 473 - 485
  • [29] CUREs in biochemistrywhere we are and where we should go
    Bell, Jessica K.
    Eckdahl, Todd T.
    Hecht, David A.
    Killion, Patrick J.
    Latzer, Joachim
    Mans, Tamara L.
    Provost, Joseph J.
    Rakus, John F.
    Siebrasse, Erica A.
    Bell, J. Ellis
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2017, 45 (01) : 7 - 12
  • [30] Digital Skills in Contemporary Schools - Where We Are and Where We Should Go
    Pyzalski, Jacek
    NEW MEDIA PEDAGOGY: RESEARCH TRENDS, METHODOLOGICAL CHALLENGES, AND SUCCESSFUL IMPLEMENTATIONS, NMP 2023, 2024, 2130 : 75 - 84